Over the last five years the National Women’s Health Network has, on numerous occasions, weighed in on the Food and Drug Administration’s (FDA) review of flibanserin, a drug intended to treat female sexual dysfunction.

Let’s face it, nearly all of us have had challenges with our sex lives at one time or another. And no wonder! We live in a culture that is obsessed with women’s sexuality and sexual performance and the pharmaceutical industry...

The cultural impact and huge profitability of male-targeted impotence drugs has prompted a rapidly accelerating race to create similar drug treatments for women. Despite more than a decade of research and millions of dollars spent on development, the Food and...

Food and Drug Administration Scientific Workshop on Female Sexual Interest/Arousal Disorder